Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 37.

Oikonomidi, A; Lewczuk, P; Kornhuber, J; Smulders, Y; Linnebank, M; Semmler, A; Popp, J (2016). Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. Journal of Neurochemistry, 139(2):324-332.

Semmler, A; Heese, P; Stoffel-Wagner, B; Muschler, M; Heberlein, A; Bigler, L; Prost, J C; Frieling, H; Kornhuber, J; Banger, M; Bleich, S; Hillemacher, T; Linnebank, M (2015). Alcohol abuse and cigarette smoking are associated with global DNA hypermethylation: results from the German Investigation on Neurobiology in Alcoholism (GINA). Alcohol, 49(2):97-101.

Lindlau, A; Widmann, C N; Putensen, C; Jessen, F; Semmler, A; Heneka, M T (2015). Predictors of hippocampal atrophy in critically ill patients. European Journal of Neurology, 22(2):410-415.

Semmler, A; Garber, Samuel J; Moskau, S; Frisch, C; Eter, N; Schlegel, U; Linnebank, M (2013). An efficient method for fractionated whole rodent brain radiation. Neurological Research, 35(4):355-359.

Gonzenbach, R R; Kong, Y; Beck, B; Buck, A; Weller, M; Semmler, A (2013). High-dose praziquantel therapy for cerebral sparganosis. Journal of Neurology, 260(5):1423-1425.

Semmler, A; Moskau-Hartmann, S; Stoffel-Wagner, B; Elger, C E; Linnebank, M (2013). Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism. Clinical Chemistry and Laboratory Medicine, 51(3):665-669.

Farkas, M; Keskitalo, S; Smith, D E C; Bain, N; Semmler, A; Ineichen, B; Smulders, Y; Blom, H; Kulic, L; Linnebank, M (2013). Hyperhomocysteinemia in Alzheimer's disease: The hen and the egg? Journal of Alzheimer's disease : JAD, 33(4):1097-1104.

Semmler, A; Okulla, T; Kaiser, M; Seifert, Burkhardt; Heneka, M T (2013). Long-term neuromuscular sequelae of critical illness. Journal of Neurology, 260(1):151-157.

Semmler, A; Prost, J C; Smulders, Y; Smith, D; Blom, H; Bigler, L; Linnebank, M (2013). Methylation metabolism in sepsis and systemic inflammatory response syndrome. Scandinavian Journal of Clinical and Laboratory Investigation, 73(5):368-372.

Francis, S M S; Tan, M E; Fung, P R; Shaw, J G; Semmler, A; Nataatmadja, M; Bowman, R V; Fong, K M; Yang, I A (2013). Peripheral compartment innate immune response to Haemophilus influenzae and Streptococcus pneumoniae in chronic obstructive pulmonary disease patients. Innate immunity, 19(4):428-437.

Semmler, A; Widmann, C N; Okulla, T; Urbach, H; Kaiser, M; Widman, G; Mormann, F; Weide, J; Fliessbach, K; Hoeft, A; Jessen, F; Putensen, C; Heneka, M T (2013). Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. Journal of Neurology, Neurosurgery, and Psychiatry, 84(1):62-69.

Linnebank, M; Moskau, S; Semmler, A; Hoefgen, B; Bopp, G; Kallweit, U; Maier, W; Schütz, C G; Wüllner, U (2012). A possible genetic link between MTHFR genotype and smoking behavior. PLoS ONE, 7(12):e53322.

Heese, P; Linnebank, M; Semmler, A; Muschler, M A N; Heberlein, A; Frieling, H; Stoffel-Wagner, B; Kornhuber, J; Banger, M; Bleich, S; Hillemacher, T (2012). Alterations of homocysteine serum levels during alcohol withdrawal are influenced by folate and riboflavin: Results from the German investigation on neurobiology in alcoholism (GINA). Alcohol and Alcoholism, 47(5):497-500.

Linnebank, M; Moskau, S; Semmler, A; Widman, G; Weller, M; Kallweit, U; Elger, C E (2012). Antiepileptic drugs and vitamin B6 plasma levels in adult patients. Epilepsy Research, 101(1-2):182-184.

Linnebank, M; Moskau, S; Kowoll, A; Semmler, A; Bangard, C; Vogt-Schaden, M; Egerer, G; Schackert, G; Reichmann, H; Schmidt-Wolf, I G H; Pels, H; Schlegel, U (2012). Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma. British Journal of Cancer:1-4.

Zorina, O I; Haueis, P; Semmler, A; Marti, I; Gonzenbach, R R; Guzek, M; Kullak-Ublick, G A; Weller, M; Russmann, S (2012). Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients. Pharmacoepidemiology and Drug Safety, 21(8):872-880.

Smith, D E C; Smulders, Y M; Blom, H J; Popp, J; Jessen, F; Semmler, A; Farkas, M; Linnebank, M (2012). Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid. Clinical Chemistry and Laboratory Medicine, 50(9):1641-1647.

Semmler, A; Frisch, C; Smith, D; Blom, H; Linnebank, M (2012). The ratio of S-adenosylmethione and S-adenosyl-homocysteine is increased in the brains of newborn rats in a model of valproic acid teratogenicity. Toxicology, 293(1-3):132-133.

Kühnlein, P; Jung, H H; Farkas, M; Keskitalo, S; Ineichen, B; Jelcic, I; Petersen, J; Semmler, A; Weller, M; Ludolph, A C; Linnebank, M (2011). The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is a possible risk factor for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 12(2):136-139.

Linnebank, M; Moskau, S; Semmler, A; Widman, G; Stoffel-Wagner, B; Weller, M; Elger, C E (2011). Antiepileptic drugs interact with folate and vitamin B12 serum levels. Annals of Neurology, 69(2):352-359.

Guzek, M; Zorina, O I; Semmler, A; Gonzenbach, R R; Huber, M; Kullak-Ublick, G A; Weller, M; Russmann, S (2011). Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System). Pharmacoepidemiology and Drug Safety, 20(9):930-938.

Semmler, A; Moskau, S; Lutz, H; Meyer, P; Linnebank, M (2011). Haplotype analysis of the 5,10-methylenetetrahydrofolate reductase (MTHFR) c.1298A>C (E429A) polymorphism. BMC Research Notes, 4:439.

Moskau, S; Smolka, K; Semmler, A; Schweichel, D; Harbrecht, U; Müller, J; Pohl, C; Klockgether, T; Linnebank, M (2010). Common genetic coagulation variants are not associated with ischemic stroke in a casecontrol study. Neurological Research, 32(5):519-522.

Ackermann, R; Semmler, A; Maurer, G D; Hattingen, E; Fornoff, F; Steinbach, J P; Linnebank, M (2010). Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites. Journal of Neuro-Oncology, 97(3):425-427.

Klotz, L; Farkas, M; Bain, N; Keskitalo, S; Semmler, A; Ineichen, B; Jelcic, J; Klockgether, T; Kösch, H; Weller, M; Linnebank, M (2010). The variant methylenetetrahydrofolate reductase c.1298A > C (p.E429A) is associated with multiple sclerosis in a German case-control study. Neuroscience Letters, 468(3):183-185.

Semmler, A; Moskau, S; Grigull, A; Farmand, S; Klockgether, T; Smulders, Y; Blom, H; Zur, B; Stoffel-Wagner, B; Linnebank, M (2010). Plasma folate levels are associated with the lipoprotein profile: a retrospective database analysis. Nutrition Journal, 9:31.

Linnebank, M; Popp, J; Smulders, Y; Smith, D; Semmler, A; Farkas, M; Kulic, L; Cvetanovska, G; Blom, H; Stoffel-Wagner, B; Kölsch, H; Weller, M; Jessen, F (2010). S-Adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegenerative Diseases, 7(6):373-378.

Semmler, A; Farmand, S; Moskau, S; Stoffel-Wagner, B; Linnebank, M (2010). The G allele of transcobalamin 2 c.776C→G is associated with an unfavorable lipoprotein profile. Annals of Nutrition & Metabolism, 57(2):112-115.

Semmler, A. Zur Ätiologie und den Langzeitfolgen der septischen Enzephalopathie. 2010, University of Zurich, Faculty of Medicine.

Linnebank, M; Moskau, S; Jurgens, A; Simon, M; Semmler, A; Orlopp, K; Glasmacher, A; Bargart, C; Vogt-Schaden, M; Urbach, H; Schmidt-Wolf, I G; Pels, H; Schlegel, U (2009). Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. Neuro-Oncology, 11(1):2-8.

Semmler, A; Bao, X; Cao, G; Köhler, W; Weller, M; Aubourg, P; Linnebank, M (2009). Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample. Journal of Neurology, 256(8):1277-1280.

Moskau, S; Semmler, A; Stoffel-Wagner, B; Linnebank, M (2009). Plasma homocysteine levels after acute stroke and in the convalescent phase. Canadian Journal of Neurological Sciences, 36(6):789-790.

Semmler, A; Moskau, S; Stoffel-Wagner, B; Weller, M; Linnebank, M (2009). The effect of MTHFR c.677C>T on plasma homocysteine levels depends on health, age and smoking. Clinical and Investigative Medicine, 32(6):E310-E314.

Semmler, A; Köhler, W; Jung, H H; Weller, M; Linnebank, M (2008). Therapy of X-linked adrenoleukodystrophy. Expert Review of Neurotherapeutics, 8(9):1367-1379.

Hillemacher, T; Frieling, H; Moskau, S; Muschler, M A N; Semmler, A; Kornhuber, J; Klockgether, T; Bleich, S; Linnebank, M (2008). Global DNA methylation is influenced by smoking behaviour. European Neuropsychopharmacology, 18(4):295-298.

Semmler, A; Smulders, Y; Struys, E; Smith, D; Moskau, S; Blom, H; Linnebank, M (2008). Methionine metabolism in an animal model of sepsis. Clinical Chemistry and Laboratory Medicine, 46(10):1398-1402.

Linnebank, M; Semmler, A; Moskau, S; Smulders, Y; Blom, H; Simon, M (2008). The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiforme. Neuro-Oncology, 10(4):548-552.

This list was generated on Tue Oct 17 14:06:58 2017 CEST.